Evidence map›Paper›PMID 37394501›Full record

ArticlePediatrics2023

Reflections From School Communities in Underserved Populations on Childhood COVID-19 Vaccination.

Elizabeth R Pulgaron, Emily M D'Agostino, Sara B Johnson, Linda K Ko, Paul K Drain, Miriana C Duran, Dana Keener Mast, Shelley Kay, Marcus A Layer, Tara Kenworthy and 1 more

Open access · greenAbstract read
In one paragraph

Article in Pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Elizabeth R Pulgaron *Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida.
Emily M D'Agostino *Departments of Orthopedic Surgery.
Sara B JohnsonDivision of General Pediatrics, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland.
Linda K KoDepartment of Health Systems and Population Health.
Paul K DrainGlobal Health, Medicine, and Epidemiology, University of Washington, Seattle, Washington.
Miriana C DuranDepartment of Health Systems and Population Health.
Dana Keener MastICF, Reston, Virginia.
Shelley KayICF, Reston, Virginia.
Marcus A LayerDuke Clinical Research Institute, Durham, North Carolina.
Tara KenworthyDepartment of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida.
Ann DozierPublic Health Sciences, University of Rochester, Rochester, New York.
Institute of Population, Health and Development · VNUniversity of Miami · USClinical Research Institute · USDuke University · USJohns Hopkins University · USUniversity of Rochester · USUniversity of Washington · US

Funding

COVID-19 Supplement - Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)U24TR001608 · NCATS · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K., HERNANDEZ, ADRIAN · 2016 to 2022
$177.0M
RADx-UP SAY YES COVID Test Study (S4)U24MD016258 · NIMHD · DUKE UNIVERSITY · PI COHEN-WOLKOWIEZ, MICHAEL, DAVE, GAURAV J · 2020 to 2023
$116.7M
SARS-CoV-2 Screening and Diagnostic testing for return to K-12 schoolsOT2HD107559 · NICHD · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K., ZIMMERMAN, KANECIA OBIE · 2021 to 2022
$5.0M
Support for Safe Return to in-Person School: COVID-19 Testing, Learning, and Consultation (School TLC)OT2HD107555 · NICHD · ICF MACRO, INC. · PI GOLDMAN, JENNIFER LYNN, KEENER MAST, DANA · 2021 to 2022
$5.0M
COV-IDD: Testing for COVID-19 in high risk children with intellectual and developmental disabilitiesOT2HD107553 · NICHD · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN, FOXE, JOHN J · 2021 to 2022
$4.0M
Using COVID-19 testing and risk communication strategies to accelerate students return to schoolOT2HD107544 · NICHD · UNIVERSITY OF WASHINGTON · PI KO, LINDA K. · 2021 to 2022
$4.0M
Maximizing Child Health and Learning Potential:How to Promote A School Culture of Safety in the era of COVID-19OT2HD108111 · NICHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GWYNN, LISA A., PULGARON, ELIZABETH ROSE · 2021 to 2022
$3.6M
The Hopkins Population CenterP2CHD042854 · NICHD · JOHNS HOPKINS UNIVERSITY · PI Alison Gemmill · 2021 to 2026
$3.0M
Social, ethical, and behavioral factors in the return to school among underserved communities in MarylandOT2HD108110 · NICHD · JOHNS HOPKINS UNIVERSITY · PI EDWARDS, LORECE V, HAGER, ERIN R · 2021 to 2021
$1.5M
NCATS NIH HHS U24 TR001608NIAAA NIH HHS HHSN275201000003CNICHD NIH HHS HHSN275201000003INICHD NIH HHS OT2 HD107544NICHD NIH HHS OT2 HD107553NICHD NIH HHS OT2 HD107555NICHD NIH HHS OT2 HD107559NICHD NIH HHS OT2 HD108110NICHD NIH HHS OT2 HD108111NICHD NIH HHS P2C HD042854NIMHD NIH HHS U24 MD016258
6 · The paper itself

Abstract

objectivesOutbreaks in vaccine-preventable diseases among children have increased, primarily among under- or unvaccinated subgroups. The influence and interaction of a child's school community on parental health care decisions, such as vaccination, has not been explored. Our study examined childhood coronavirus disease 2019 (COVID-19) vaccine hesitancy within the context of school communities.

methodsThis study combines data from 4 independent research studies funded by the National Institutes of Health Rapid Acceleration of Diagnostics Underserved Populations Return to School Initiative. We examined focus group data to better understand the apprehension surrounding parental and child COVID-19 vaccination among underserved school populations.

resultsAcross all study sites, 7 main themes emerged with regard to COVID-19-related vaccination concerns for children: (1) potential side effects, (2) vaccine development, (3) misinformation (subthemes: content of vaccine and negative intent of the vaccine), (4) vaccine effectiveness, (5) timing of vaccine administration/availability for children, (6) fear of needles, and (7) mistrust.

conclusionsSchool settings offered unique access to youth and family perspectives in underserved communities. Our studies highlighted several factors contributing to COVID-19 vaccine hesitancy in school communities, which align with existing literature on vaccine hesitancy. These concerns centered primarily on potential harm of vaccines, as well as misinformation, mistrust, and timing of vaccines. Related recommendations for increasing vaccination rates are provided. Developing specific strategies that address parent and child concerns will be critical to reducing health inequities related to COVID-19 vaccination.

Indexed as

COVID-19VaccinesAccelerationAdolescentChildCOVID-19 VaccinesHumansVaccinationVulnerable PopulationsCOVID-19 VaccinesVaccines

Identifiers

PMID37394501
PMCPMC10312275
OpenAlexW4382918437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.